ANOxA Corp.
1Patents
1Active
1Granted
36Portfolio score
Filing activity: May 1, 2007 → May 1, 2007 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8217049B2 | Use of type V phosphodiesterase inhibitors in the treatment of exercise induced pulmonary hemorrhage in the equine | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.